NSPRライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Stats
本日の出来高	10 238.00
平均出来高	34 706.00
時価総額	46.80M
EPS	$0 ( 2024-04-04 )
次の収益日	( $-0.150 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.44
ATR14	$0.0230 (1.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-23	Kester Thomas J	Buy	29 032	Common Stock
2024-01-23	Kester Thomas J	Buy	11 098	Options to purchase common stock (right to buy)
2024-01-23	Verta Patrick	Buy	85 720	Common Stock
2024-01-23	Verta Patrick	Buy	32 768	Options to purchase common stock (right to buy)
2024-01-23	Gleason Shane Thomas	Buy	238 625	Common Stock

INSIDER POWER
98.06
Last 99 transactions
Buy: 7 620 190 \| Sell: 72 371

InspireMD Inc 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

InspireMD Inc 財務諸表

Annual	2023
収益:	$6.21M
総利益:	$1.81M (29.12 %)
EPS:	$-0.820

FY	2023
収益:	$6.21M
総利益:	$1.81M (29.12 %)
EPS:	$-0.820

FY	2022
収益:	$5.17M
総利益:	$1.12M (21.60 %)
EPS:	$-2.35

FY	2021
収益:	$4.50M
総利益:	$754 000 (16.77 %)
EPS:	$-2.03

Financial Reports:

No articles found.

InspireMD Inc

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.